Novel theranostic approaches to neovascularized atherosclerotic plaques

• Published in: Atherosclerosis Vol. 374; pp. 1 - 10
• Main Authors: Boswell-Patterson, Christie A., Hétu, Marie-France, Pang, Stephen C., Herr, Julia E., Zhou, Jianhua, Jain, Shagun, Bambokian, Alexander, Johri, Amer M.
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 01.06.2023
• Subjects: Angiogenesis; Atherosclerosis - diagnostic imaging; Atherosclerosis - pathology; Atherosclerosis - therapy; Cardiovascular; Carotid; Contrast; Humans; Neovascularization, Pathologic; Plaque; Plaque, Atherosclerotic - pathology; Precision Medicine; Theranostic; Ultrasonography; Ultrasound; Angiogenesis; Cardiovascular; Carotid; Theranostic; Ultrasound; Contrast; Plaque
• ISSN: 0021-9150; 1879-1484
• DOI: 10.1016/j.atherosclerosis.2023.04.008

As the global burden of atherosclerotic cardiovascular disease continues to rise, there is an increased demand for improved imaging techniques for earlier detection of atherosclerotic plaques and new therapeutic targets. Plaque lesions, vulnerable to rupture and thrombosis, are thought to be responsible for the majority of cardiovascular events, and are characterized by a large lipid core, a thin fibrous cap, and neovascularization. In addition to supplying the plaque core with increased inflammatory factors, these pathological neovessels are tortuous and leaky, further increasing the risk of intraplaque hemorrhage. Clinically, plaque neovascularization has been shown to be a significant and independent predictor of adverse cardiovascular outcomes. Microvessels can be detected through contrast-enhanced ultrasound (CEUS) imaging, however, clinical assessment in vivo is generally limited to qualitative measures of plaque neovascularization. There is no validated standard for quantitative assessment of the microvessel networks found in plaques. Advances in our understanding of the pathological mechanisms underlying plaque neovascularization and its significant role in the morbidity and mortality associated with atherosclerosis have made it an attractive area of research in translational medicine. Current areas of research include the development of novel therapeutic and diagnostic agents to target plaque neovascularization stabilization. With recent progress in nanotechnology, nanoparticles have been investigated for their ability to specifically target neovascularization. Contrast microbubbles have been similarly engineered to carry loads of therapeutic agents and can be visualized using CEUS. This review summarizes the pathogenesis, diagnosis, clinical significance of neovascularization, and importantly the emerging areas of theranostic tool development. [Display omitted] •Plaque neovascularization is associated with adverse cardiovascular outcomes.•Review of the pathogenesis, diagnosis, and clinical significance of neovascularization.•Emerging areas of theranostic tool development for neovascularization stabilization.•Targeting neovascular sites using microcarrier drug loaded micro bubbles.